NM_024312.5:c.1017_1020dupTGCA
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024312.5(GNPTAB):c.1017_1020dupTGCA(p.Pro341CysfsTer22) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,460,826 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024312.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GNPTAB | NM_024312.5 | c.1017_1020dupTGCA | p.Pro341CysfsTer22 | frameshift_variant | Exon 9 of 21 | ENST00000299314.12 | NP_077288.2 | |
| GNPTAB | XM_011538731.3 | c.936_939dupTGCA | p.Pro314CysfsTer22 | frameshift_variant | Exon 9 of 21 | XP_011537033.1 | ||
| GNPTAB | XM_006719593.4 | c.1017_1020dupTGCA | p.Pro341CysfsTer22 | frameshift_variant | Exon 9 of 19 | XP_006719656.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | ENST00000299314.12 | c.1017_1020dupTGCA | p.Pro341CysfsTer22 | frameshift_variant | Exon 9 of 21 | 1 | NM_024312.5 | ENSP00000299314.7 | ||
| GNPTAB | ENST00000549940.5 | c.1017_1020dupTGCA | p.Pro341CysfsTer22 | frameshift_variant | Exon 9 of 11 | 1 | ENSP00000449150.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251376 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460826Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726774 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:3
- -
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 556992). This premature translational stop signal has been observed in individual(s) with GNPTAB-related conditions (PMID: 25473036). This variant is present in population databases (rs748809942, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Pro341Cysfs*22) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at